Mega Lifesciences Public Company Limited is a health and wellness company operating in over 30 developing countries, primarily in Southeast Asia, the Middle East, and Africa. The business focuses on the marketing and sale of supplements, medications, and medical nutrition products, including vitamins, probiotics, herbal remedies, and specialized care for conditions such as diabetes, heart health, and gut health. Key product brands include GOFEN, NAT B, LIVOLIN FORTE, ENAT, FERROVIT, NAT C, and NORMAGUT. The company provides market access solutions in Myanmar, Vietnam, and Cambodia and operates manufacturing facilities in Thailand. Established in 1982, the group includes subsidiaries such as PT MEGA Lifesciences Indonesia and MEGA Products Limited in Yemen. Mega Lifesciences also offers digital health tools, online health risk assessments, and operates the Wellness We care Center in Thailand for disease prevention and lifestyle modification training.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Drug Manufacturers - Specialty & Generic Homepage megawecare.com
Sector Healthcare IR page investor.megawecare.com
Tags
supplements, medical nutrition, vitamins, probiotics, herbal medicine, chronic disease management, digital health, wellness services, pharmaceutical marketing, GOFEN, NAT B, LIVOLIN FORTE, ENAT, FERROVIT, NAT C, NORMAGUT, PT MEGA Lifesciences Indonesia, MEGA Products Limited, Wellness We care Center
Press page —

Metrics

Valuation  
Market cap ฿ 30.297B
Market cap (USD) $ 891.752M
P/E 13.83
PEG —
P/BV 2.93
P/S 2.12
P/OCF 10.94
P/FCF —
Dividend yield 4.6%
Turnover / mcap —
Returns  
ROE 19.0%
ROI 18.7%
ROIC 18.7%
Profit margin 13.4%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -5.2%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 9
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Revenue 14.278B 15.447B 15.776B 15.767B 14.182B 12.613B — 7.581B 9.64B 8.842B 8.097B
Net profit 1.912B 2.012B 1.993B 2.242B 1.947B 1.393B — 798.76M 1.113B 794.91M 695.75M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Share price 33.5 33.25 40.25 46.75 50.5 35.75 28.75 28.75 44 25.25 16.5
P/BV 3.02 3.14 3.91 4.78 5.89 4.7 4.71 4.7 7.8 4.97 3.52

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Health Calculators

Make informed decisions about your health with our easy-to-use health calculators.

Online Health Risk Assessment Tool

Online Health Risk Assessment Tool

Online Health Risk Assessment Tool

BMI (Body Mass Index) Calculator

BMI (Body Mass Index) Calculator

BMI (Body Mass Index) Calculator

BMR (Basal Metabolic Rate) Calculator

BMR (Basal Metabolic Rate) Calculator

BMR (Basal Metabolic Rate) Calculator

Liver Risk Assessment Calculator

Liver Risk Assessment Calculator

Liver Risk Assessment Calculator

Body Fat Calculator

Body Fat Calculator

Body Fat Calculator

Fat Loss Calculator

Fat Loss Calculator

Fat Loss Calculator

Food Calorie Calculator

Food Calorie Calculator

Food Calorie Calculator

Heart Rate Zone Calculator

Heart Rate Zone Calculator

Heart Rate Zone Calculator

Ideal Weight Calculator

Ideal Weight Calculator

Ideal Weight Calculator

Waist to Hip Ratio Calculator

Waist to Hip Ratio Calculator

Waist to Hip Ratio Calculator

Fiber Calculator

Fiber Calculator

Fiber Calculator

Diabetes Risk Calculator

Diabetes Risk Calculator

Diabetes Risk Calculator

Period Cycle Calculator

Period Cycle Calculator

Period Cycle Calculator

Sleep Debt Calculator

Sleep Debt Calculator

Sleep Debt Calculator

Sleep Cycle Calculator

Sleep Cycle Calculator

Sleep Cycle Calculator

Sleep Length Calculator

Sleep Length Calculator

Sleep Length Calculator

Pregnancy Due Date Calculator

Pregnancy Due Date Calculator

Pregnancy Due Date Calculator

Pregnancy Test Calculator

Pregnancy Test Calculator

Pregnancy Test Calculator

Pregnancy Weight Gain Calculator

Pregnancy Weight Gain Calculator

Pregnancy Weight Gain Calculator

Acne Quiz

Acne Quiz

Acne Quiz

Copyright © 2026 MEGA Lifesciences Public Company Limited. All Rights Reserved.

Right of Shareholders to propose Agenda and Nominees to be elected as Company's Directors, and submit questions in advance for the 2027 Annual General Meeting of Shareholders ______________________________________________________________________ This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement. If you would like to see the full details of this information, please click view "full details" in attached file.

Declaration of interim dividend of 2026 Bull 3 Bear 0 Capital return

Dividend payment / Omitted dividend payment Subject : Cash dividend payment Date of Board resolution : 13-Aug-2026 Type of dividend payment : Cash dividend payment Record date for the right to receive : 27-Aug-2026 dividends Ex-dividend date : 26-Aug-2026 Payment for : Common shareholders Cash dividend payment (baht per share) : 0.85 Par value (baht) : 0.50 Payment date : 11-Sep-2026 Paid from : Operating period from 01-Jan-2026 to 30-Jun-2026 and retained Earnings Remark : (1) The dividend of Baht 0.15 per share, paid from net profits and retained earnings from tax exempt income, the shareholder will be subject to a withholding tax of 10% and not entitled to a tax credit. (2) The dividend of Baht 0.70 per share, paid from the net profit and retained earnings with 20% Corporate Income Tax, the shareholder will be subject to withholding tax of 10% and can be credited 20/80 of the dividend. ______________________________________________________________________ The company hereby certifies that the information above is correct and complete. Signature _________________ ( Mr.VIVEK DHAWAN ) DIRECTOR Authorized person to disclose information ______________________________________________________________________ This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement. If you would like to see the full details of this information, please click view "full details" in attached file.

Prompts

Mega Lifesciences Public Company Limited (ticker MEGA), listed in Thailand.

ETFs Holding Mega Lifesciences Public Company Limited

ETF Weight in ETF Shares Market value As of
AVEE 0.02% 20,900 $ 22.535K Nov 16, 2026
DEXC 0.01% 30,300 $ 31.623K Nov 12, 2026
AVSE 0.01% 24,100 $ 25.985K Nov 16, 2026
AVXC 0.01% 39,200 $ 42.267K Nov 16, 2026
DFSE 0.01% 45,100 $ 47.07K Nov 12, 2026
DFEM 0.00% 235,800 $ 246.098K Nov 12, 2026
DFAX 0.00% 234,400 $ 244.637K Nov 12, 2026
AVEM 0.00% 673,100 $ 725.757K Nov 16, 2026
AVES 0.00% 54,200 $ 58.44K Nov 16, 2026